
Cogent Biosciences Inc (COGT)
NASDAQ
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -41.001 | -51.166 | -47.038 | -49.816 | -29.926 | -52.633 | -62.649 | -79.79 |
Return on Equity (%) | 69.501 | -606.744 | -69.205 | -56.156 | -32.204 | -59.687 | -74.935 | -99.539 |
Return on Invested Capital (%) | 18950.725 | -85.485 | -72.604 | -62.392 | -34.139 | -64.251 | -83.844 | -111.064 |
Operating Margin (%) | -304.928 | -354.757 | -141.486 | -950.426 | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | -305.706 | -354.921 | -141.486 | -950.426 | N/A | N/A | N/A | N/A |
Book Value Per Share | 2.774 | 2.004 | 1.036 | 3.827 | 2.933 | 2.714 | 2.294 | 1.318 |
Earnings Per Share | -2.505 | -1.149 | -1.038 | -2.313 | -1.646 | -2.004 | -2.232 | -2.315 |
Cash Per Share | 2.771 | 1.852 | 1.22 | 7.487 | 5.003 | 1.999 | 0.618 | 0.888 |
Working Capital Per Share | 3.057 | 1.865 | 0.892 | 7.166 | 4.681 | 3.403 | 2.698 | 2.178 |
Operating Profit Per Share | 0.819 | 0.324 | 0.734 | 0.243 | N/A | N/A | N/A | N/A |
EBIT Per Share | -2.499 | -1.149 | -1.038 | -2.313 | -1.646 | -2.004 | -2.232 | -2.315 |
EBITDA Per Share | -2.499 | -1.149 | -1.038 | -2.313 | -1.646 | -2.004 | -2.232 | -2.315 |
Free Cash Flow Per Share | -2.53 | -1.175 | -1.079 | -1.981 | -1.609 | -1.918 | -2.226 | -2.332 |
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 10,2M | 30,06M | 30,66M | 32,35M | 43,81M | 69,89M | N/A | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 873,23M |
Ratio cours/bénéfice | -1,05 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 2,73 |
Ratio prix/valeur comptable | 1,04 |
Rendement de dividende | - |
Actions en circulation | 113,85M |
Volume moyen (1 semaine) | 1,68M |
Volume moyen (1 mois) | 1,39M |
Variation sur 52 semaines | 7,72% |
Plus haut sur 52 semaines | 12,61 |
Plus bas sur 52 semaines | 5,73 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales